NP202 for Treatment of Post -STEMI Left Ventricular Systolic Dysfunction

NCT02557217 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

ST Elevation Myocardial Infarction

Interventions

DRUG: NP202
OTHER: Placebo

Sponsor

Armaron Bio Pty Ltd